LEONARD LARINO: Open Payments
NPI 1588237580 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 31 payments from 16 companies in 2025. Trend: 2023 $1,612 · 2024 $1,724 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $142 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| PFIZER INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Kestra Medical Technology Services, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ABIOMED | 1 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Amgen Inc. | 2 | $37 |
| ENDOTRONIX, INC. | 1 | $35 |
Products named: CAMZYOS, VERQUVO, ELIQUIS, Assure WCD, WAINUA, AMVUTTRA, REPATHA, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR.
Industry payments across CA — which companies pay providers there.
